Following his father's footsteps (Dr. Jean Bour, a cardiologist in France), Frank Bour dedicated his entire professional life to developing a technology (PhysioFlow®) for non-invasive haemodynamic monitoring at rest ad during exercise. He owns several patents, has been very involved in validation and applied research work, and leads the company that focuses on developing this technology and making it available to practitioners and research scientists world-wide.
Frank Bour is currently a 3rd and final year member of the Paris University PhD programme (in exercise science) .
Signal-morphology impedance cardiography is a non-invasive tool to predict responses to exercise based cardiac rehabilitation in chronic heart failure patients